Long-Acting siRNA Delivery - Process Development & Scale-up Services

Evonik offers process development and scale-up services for long-acting microparticle formulations, with a strong focus on siRNA drug delivery programs from successful feasibility studies. Leveraging proprietary continuous microencapsulation technologies, Evonik develops scalable, reproducible manufacturing processes that enable the production of material for GLP toxicology and stability studies, while ensuring process robustness and readiness for clinical and commercial manufacturing.

Benefits at a glance

  • Experience: 50+ years of process expertise and drug delivery innovation, supporting pharmaceutical development from concept through commercialization.
  • Proven: Market-tested microparticle dosage forms with demonstrated clinical and commercial success.
  • Innovative: Scalable continuous microencapsulation technologies designed to accelerate development and manufacturing.
  • Safe: Biocompatible, bioabsorbable RESOMER® and LACTEL® polymers with well-established safety profiles.
  • Trusted: Lactide/glycolide polymer technologies used in more than 60 approved pharmaceutical products worldwide

Markets & Applications